股东方面，截至2025年3月31日，稳健医疗股东户数21410户，较上次减少2643户，户均持股市值35.28 万元，户均持股数量2.76万股。 7月4日，稳健医疗今日收盘40.2元，下跌2.43%，滚动市盈率PE（当前股价与前四季度每股收益总和的 比值）达到30.74倍，总市值234.10亿元。 序号股票简称PE(TTM)PE(静)市净率总市值(元)8稳健医疗30.7433.662.05234.10亿行业平均 38.9646.134.06105.57亿行业中值43.1140.682.5868.23亿1依依股份17.7118.692.1340.20亿2科思股份 18.4112.792.6371.92亿3珀莱雅19.5820.685.59320.96亿4敷尔佳21.6919.712.27130.34亿5豪悦护理 22.3022.582.5887.49亿6诺邦股份27.6630.552.0329.09亿7爱美客27.8726.686.34522.33亿9百亚股份 36.6140.187.31115.58亿10力合科创37.0839.411.3396.73亿11润本股份39.5340.685.75122.11亿12 ...

Company Overview - Company name is稳健医疗, which focuses on the research, production, and sales of cotton-based products [1] - Main products include high-end wound dressings, traditional wound care and bandaging products, surgical consumables, infection protection products, health personal care products, cotton towels, cotton sanitary napkins, cotton wet wipes, non-woven consumer products, baby products, and adult clothing [1] - The company has consistently ranked among the top three in China's medical dressing exports for several years [1] Financial Performance - For Q1 2025, the company reported revenue of 2.605 billion yuan, a year-on-year increase of 36.47% [2] - Net profit for the same period was 249 million yuan, also reflecting a year-on-year growth of 36.26% [2] - The sales gross margin stood at 48.46% [2] Market Position - The company's current rolling price-to-earnings (PE) ratio is 30.45, while the average PE ratio for the beauty and personal care industry is 39.12 [1][2] - The industry median PE ratio is 42.46, placing the company at 13th in the industry ranking [1] - The total market capitalization of the company is 23.188 billion yuan [1] Capital Flow - On June 26, the company experienced a net outflow of main funds amounting to 2.0955 million yuan, with a total outflow of 24.8019 million yuan over the past five days [1]

相关上市企业：金发拉比（002762）；森马服饰（002563）；安奈儿（002875）；稳健医疗 （300888）；朗姿股份（002612）等 相关企业：上海巨臣婴童服饰股份有限公司；深圳市心宇婴童服饰有限公司；深圳市心宇婴童服饰有限 公司；青岛心心宜儿婴童服饰有限公司；遵义娃娃国婴童服装用品有限公司；英薇宝（北京）婴童服饰 有限公司；重庆娃娃国婴童服装用品有限公司等 关键词：产业链；出生人数；生育补贴政策；婴童服饰行业规模；竞争格局；重点企业；发展趋势 一、行业概况 婴童服饰是指为0-14岁（有时扩展到0-16岁）儿童提供的服装，涵盖婴儿服装、幼儿服装、小童服装、 中童服装和大童服装等多个年龄段。婴童服饰的设计和生产需要遵循特定的标准和规范，以确保产品的 质量和安全性，同时满足不同年龄段、不同性别、不同风格和不同功能的需求。 内容概要：婴童服饰是指为0-14岁（有时扩展到0-16岁）儿童提供的服装。近年来，随着国民经济的平 稳增长和人均可支配收入的提高，居民消费支出能力不断提升，叠加优生优育理念的不断普及和强化， 我国婴童人均衣着消费支出持续上升。此外，随着我国三胎全面放开，以及90后、00后等相继进入婚 ...

Company Overview - Company name is稳健医疗, which closed at 50.47 yuan on June 10, with a 2.25% increase, resulting in a rolling PE ratio of 38.59 times and a total market value of 29.39 billion yuan [1] - The main business of the company includes research, production, and sales of cotton-based products, with key products being high-end wound dressings, traditional wound care products, surgical consumables, infection protection products, and personal health products [1] Financial Performance - For Q1 2025, the company reported revenue of 2.605 billion yuan, a year-on-year increase of 36.47%, and a net profit of 249 million yuan, also up 36.26%, with a gross profit margin of 48.46% [2] - The company's PE ratio is 38.59 (TTM) and 42.26 (static), with a price-to-book ratio of 2.58 [2] Industry Comparison - The average PE ratio for the beauty and personal care industry is 44.04, with a median of 49.17, placing the company at 14th in the industry ranking [1][2] - The total market value of the industry averages 115.99 billion yuan, with the median at 74.78 billion yuan [2] Market Position - The company has consistently ranked among the top three exporters of medical dressings in China for several years [1] - The "winner" brand has entered over 2,000 hospitals and nearly 40,000 pharmacies in China, with a significant presence in major chains [1]

【导读】*ST金比控股股东、实际控制人筹划股份协议转让事宜，股票自6月5日开市起停牌 见习记者杨晨 6月4日晚间，*ST金比发布公告称，其控股股东、实际控制人林浩亮、林若文正在筹划公司股份协议转 让事宜，具体方案尚待沟通确定。根据有关规定，该公司股票自6月5日开市起停牌，预计停牌时间不超 过2个交易日。 值得一提的是，*ST金比同日发布了《股票交易异常波动公告》：由于公司股票交易价格连续三个交易 日（2025年5月30日、2025年6月3日、2025年6月4日）收盘价格涨幅偏离值累计超过12%，根据《深圳 证券交易所股票上市规则》的相关规定，达到规则标准的股票交易异常波动。 针对股票异动情况，金发拉比表示，公司已从控股股东和实际控制人处获悉，公司大股东正在筹划公司 控制权变更事宜，除此之外，不存在关于本公司的应披露而未披露的重大事项或处于筹划阶段的重大事 项。 2024年，金发拉比在已持有韩妃投资49%股份的基础上，又收购了珠海韩妃和中山韩妃各51%股份，拓 展在医美服务领域的业务布局。不过，韩妃投资为金发拉比的参股企业，未达到控股或报表合并的标 准，2024年度母婴消费品板块仍是金发拉比主要业绩来源，因此， ...

*ST金比表示，将多重措施争取2025年业绩快速增长，尽快撤销退市风险警示。首先，2025年原有业务 体系将大力拓展新的渠道和合作伙伴，开发新产品，利用AI辅助销售推广，通过智能化、数字化赋能 会员管理、销售体系、线上线下（300959）联动，为公司带来业绩快速增长。 其次，2024年末，*ST金比收购控股的中山韩妃和珠海韩妃(2024年销售收入7006万元，净利润712万 元)，公司将在2025年助力中山韩妃和珠海韩妃充分利用AI辅助工具，赋能会员销售管理体系，开展新 的服务项目，促使其贡献更多的销售收入和利润，推动"母婴+医美"双主业的落地并快速发展。 6月4日晚，母婴品牌运营商*ST金比（002762）披露公告称，近日收到控股股东、实际控制人林浩亮先 生、林若文女士的通知，其正在筹划公司股份协议转让事宜，具体方案尚待沟通确定。公司股票自6月5 日开市起停牌，预计停牌时间不超过2个交易日。 资料显示，*ST金比主业专注于母婴消费品行业，是国内较早从事母婴消费品(婴童服饰、婴幼儿棉制用 品及各类母婴用品)的研发、设计、生产、销售和服务的企业之一，产品线对母婴"穿"、"用"类产品基 本实现全覆盖，拥有"拉比( ...

Summary of the Conference Call for稳健医疗 Company Overview - **Company Name**: 稳健医疗 (Steady Medical) - **Business Segments**: The company operates in two main segments: consumer products (52% of revenue) and medical supplies (48% of revenue) as of Q1 2025. The consumer products segment contributes approximately 60% to the overall operating profit margin [2][3]. Financial Performance - **Revenue Growth**: From 2013 to 2019, the company achieved a revenue growth rate of 24%, primarily driven by the consumer products segment. In Q1 2025, both medical supplies and consumer products segments returned to double-digit growth [2][5]. - **Profitability**: The company expects a 50% year-on-year increase in net profit attributable to the parent company in 2025, with the medical segment projected to grow by approximately 38% [4][19]. Market Dynamics - **Market Size**: The market for wet and dry cotton wipes is valued at over 10 billion yuan, with an expected growth rate of about 7%. The sanitary napkin market is around 100 billion yuan, with a projected retail price increase of about 3% in the coming years [2][6]. - **Market Share**: 全棉时代 (Cotton Era) holds over 15% market share in the facial towel category, while the overall market share of the company exceeds 20%, maintaining the leading position in this category [2][6]. Product Performance - **Core Products**: The core products, including dry and wet cotton wipes and sanitary napkins, have shown significant growth. The sanitary napkin brand, 奈斯公主 (Nice Princess), experienced over 70% year-on-year revenue growth in Q1 2025 [2][7][11]. - **Innovation**: The company introduced a hanging cotton wipe product, which significantly boosted market performance despite being a minor innovation [10]. Consumer Education and Brand Strategy - **Consumer Education**: The company emphasizes consumer education to enhance awareness of the quality and safety of cotton products, which has led to a recovery in double-digit growth for dry and wet cotton wipes [8][9]. - **Brand Positioning**: As a pioneer in the market, the company has established a strong brand identity, leveraging its unique product offerings and consumer education to differentiate itself from competitors [9][20]. Sales Channels - **Channel Distribution**: The consumer products segment has a channel distribution of approximately 60% online and 40% offline. The online sales have been particularly strong on platforms like Douyin [12][13]. - **Store Expansion**: The company operates 487 stores, with plans to open about 50 new stores annually while adjusting the store structure to improve performance [14]. Competitive Landscape - **Market Competition**: The low-value medical consumables market is highly competitive, with domestic brands primarily competing in the low-end market. The company aims to leverage its international presence and product quality to maintain a competitive edge [15][16]. Future Outlook - **Growth Projections**: The company anticipates strong growth in the consumer products segment, with cotton wipes expected to grow by 25% to 30% and sanitary napkins by over 50% in 2025 [18]. - **Net Profit Forecast**: The projected net profit for 2025 is 1.04 billion yuan, with continued growth expected in subsequent years [19]. - **Valuation**: The company's stock is currently valued at a PE ratio of approximately 30 times for 2025, which is considered reasonable given its diversified business model and strong product drivers [21]. Conclusion - **Investment Rating**: The company is viewed positively, with expectations of continued growth and a strong market position, leading to an optimistic outlook for future performance [22].

Core Viewpoint - The company is preparing for its upcoming shareholder meeting, outlining the procedures and rules to ensure order and efficiency during the meeting [1][2][3]. Meeting Procedures - The shareholder meeting will have a secretariat responsible for organizing the meeting and handling related matters [1]. - Attendees must respect the rights of shareholders and maintain order during the meeting [1]. - Shareholders have the right to speak and vote, but must register in advance if they wish to speak [1]. - Non-shareholders are not allowed to speak without permission from the meeting host [2]. Voting Methods - Voting will be conducted through both on-site and online methods [3]. - On-site voting requires shareholders to collect ballots upon registration [3]. - The meeting will appoint three monitors to oversee the voting process [3]. Agenda Items - The agenda includes the review of the 2024 annual report, board and supervisory committee reports, financial statements, profit distribution proposals, and various resolutions regarding the company's governance [3][4][5]. Financial Performance - The company reported a revenue of approximately 20.96 billion yuan for 2024, a decrease of 2.65% compared to 2023 [4]. - The net profit attributable to shareholders decreased by 26.88% to approximately 2.16 billion yuan [4]. - The net cash flow from operating activities dropped by 55.70% to approximately 2.32 billion yuan [4]. Business Strategy - The company aims to enhance its brand influence and market presence through various initiatives, including expanding its product offerings and optimizing store layouts [12][24]. - The company is focusing on digital transformation and innovation in product development to meet diverse consumer needs [22][25].

根据市场公开信息及5月9日披露的机构调研信息，知名私募星石投资近期对1家上市公司进行了调研， 相关名单如下： 机构简介： 北京市星石投资管理有限公司(以下简称"星石投资")成立于2007年，是国内顶尖的私募证券投资基金管 理公司之一、中国证券投资基金业协会首批特别会员，国内最早成立的阳光私募公司之一。2015年星石 投资成为国内首批百亿证券私募。十三年来星石投资开创中国私募行业多个第一，包括第一家荣获国际 权威基金奖项"晨星中国对冲基金奖"的中国私募，第一批入选MSCI全球对冲基金指数的中国私募基金 等。xa0星石投资囊括了行业国内外100多个奖项，是业内少有的实现荣誉大满贯的私募公司，其中包括 9届14座国内私募权威奖项--由中国证券报主办的"中国私募金牛奖"、首届"晨星中国对冲基金奖"，以及 19座5年期和10年期长期大奖，投资实力稳定位于行业前列。xa0十三年来，星石投资专注于股票多头策 略，组建了一只实力雄厚的40人专业投研团队，统一使用多层面驱动因素投资方法，进行全行业覆盖研 究，研究成果可复用性强，能形成强大投研合力。星石投资实行投资决策委会员领导下的多基金经理负 责制，9名基金经理共同管理旗下所 ...

Group 1 - The core viewpoint of the news highlights the performance and market position of the company, Steady Medical, in the healthcare industry, particularly in the medical dressing sector [1][2]. - As of May 9, the company's stock closed at 51.45 yuan, reflecting a 3.31% increase, with a rolling price-to-earnings (PE) ratio of 39.34 times and a total market capitalization of 29.961 billion yuan [1]. - The average PE ratio for the beauty and healthcare industry is 41.70 times, with a median of 45.39 times, placing Steady Medical at the 14th position within the industry [1][3]. Group 2 - Steady Medical specializes in the research, production, and sales of cotton-based products across various sectors, including medical, personal care, and home care [2]. - The company's main products include high-end wound dressings, traditional wound care products, infection control products, and various cotton-based personal care items [2]. - According to recent performance data, for the first quarter of 2025, the company reported revenue of 2.605 billion yuan, a year-on-year increase of 36.47%, and a net profit of 249 million yuan, also up by 36.26%, with a gross profit margin of 48.46% [2].